Cellebrite DI Ltd.
CLBT
$16.86
$0.030.18%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -283.01M | -316.92M | -103.33M | |
| Total Depreciation and Amortization | -- | 10.61M | 10.49M | 10.25M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 362.52M | 393.23M | 173.34M | |
| Change in Net Operating Assets | -- | 42.05M | 23.23M | 17.30M | |
| Cash from Operations | -- | 132.17M | 110.03M | 97.56M | |
| Capital Expenditure | -- | -8.57M | -7.65M | -6.91M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -2.75M | -2.75M | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -138.16M | -119.97M | -115.68M | |
| Cash from Investing | -- | -149.47M | -130.36M | -122.59M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 20.66M | 18.46M | 21.74M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -11.00K | -11.00K | -- | |
| Cash from Financing | -- | 20.65M | 18.45M | 21.74M | |
| Foreign Exchange rate Adjustments | -- | -1.21M | 1.16M | -252.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 2.14M | -717.00K | -3.55M | |